In Brief: Warner-Lambert
Executive Summary
Warner-Lambert: Government drops two remaining charges (conspiracy to defraud the FDA and obstruction of an agency proceeding) against former W-L VP-Quality Assurance Allan Doane in Greenbelt, Md. federal court Oct. 18. Doane was acquitted on three counts of introduction of adulterated Dilantin (phenytoin) into interstate commerce on Oct. 4, but the jury was hung on the conspiracy and obstruction charges ("The Pink Sheet" Oct. 14, p. 13)...
You may also be interested in...
Schering GMP Criminal Investigation Continues After Consent Decree
Schering-Plough faces a potential criminal case regarding GMP violations after finalizing a consent agreement with FDA May 17
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials